|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> 尿鸟苷素>> 市场分析报告 |
尿鸟苷素市场分析报告 |
|
Callisto Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... the actions of the GI hormone uroguanylin, for the treatment of chronic ... The endogenous agonists of GC-C receptor are uroguanylin and guanylin, which were discovered ... and diseases. SP-304 is an analog of uroguanylin, a natural peptide hormone produced in the ... Synergy Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... and is recruiting patients. SP-304 is an analog of uroguanylin, a natural GI hormone secreted in the gut ... Oral Proteins and Oral Peptides Market (4th Edition) by Target Disease Indication (acromegaly, celiac disease, chronic idiopathic constipation, enteric hyperoxaluria, inflammatory bowel disease and type II diabetes), Type of Molecule (protein and peptide), Technology Platforms, Biological Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others), Key Players, and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032 The oral protein and oral peptide market is expected to reach USD 1.4 billion in 2022 anticipated to grow at a CAGR of 20% during the forecast period 2022-2032 Since the introduction of the initial protein-based therapy, recombinant human insulin, in 1982 ... Global Plecanatide Api Market Research Report 2025(Status and Outlook) ... Pharmaceutical Ingredient) is a synthetic peptide analog of uroguanylin, designed to treat chronic idiopathic constipation ... Synergy Pharmaceuticals Inc (SGYP) - Financial and Strategic SWOT Analysis Review ... efforts to develop its proprietary uroguanylin-based GI platform. It is also ... developing analogs of uroguanylin, a naturally occurring human GI peptide ... plecanatide), which is structurally identical to uroguanylin, for the treatment of ... Synergy Pharmaceuticals Inc - Strategic SWOT Analysis Review ... efforts to develop its proprietary uroguanylin-based GI platform. It is also ... developing analogs of uroguanylin, a naturally occurring human GI peptide ... plecanatide), which is structurally identical to uroguanylin, for the treatment of ... |